Analysts Set Hims & Hers Health, Inc. (NYSE:HIMS) Price Target at $19.86
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has been given an average recommendation of “Moderate Buy” by the sixteen analysts that are presently covering the company, MarketBeat reports. Eight research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month […]
More Stories
HighTower Advisors LLC Has $3.95 Million Holdings in Sprott Physical Gold and Silver Trust $CEF
HighTower Advisors LLC reduced its position in Sprott Physical Gold and Silver Trust (NYSEAMERICAN:CEF – Free Report) by 32.0% during...
Innovator U.S. Equity Power Buffer ETF – May $PMAY Shares Sold by HighTower Advisors LLC
HighTower Advisors LLC reduced its holdings in shares of Innovator U.S. Equity Power Buffer ETF – May (BATS:PMAY – Free...
HighTower Advisors LLC Increases Holdings in Howmet Aerospace Inc. $HWM
HighTower Advisors LLC increased its holdings in shares of Howmet Aerospace Inc. (NYSE:HWM – Free Report) by 7.2% in the...
Fidelity MSCI Real Estate Index ETF $FREL Shares Purchased by HighTower Advisors LLC
HighTower Advisors LLC increased its stake in shares of Fidelity MSCI Real Estate Index ETF (NYSEARCA:FREL – Free Report) by...
Capital Group Core Equity ETF $CGUS Shares Bought by HighTower Advisors LLC
HighTower Advisors LLC raised its holdings in Capital Group Core Equity ETF (NYSEARCA:CGUS – Free Report) by 13.7% during the...
HighTower Advisors LLC Has $3.93 Million Stock Position in The Ensign Group, Inc. $ENSG
HighTower Advisors LLC cut its holdings in shares of The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) by 5.3% during...